Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.23
MCK's Cash-to-Debt is ranked lower than
68% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. MCK: 0.23 )
Ranked among companies with meaningful Cash-to-Debt only.
MCK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.46 Max: 3.01
Current: 0.23
0.05
3.01
Equity-to-Asset 0.15
MCK's Equity-to-Asset is ranked lower than
93% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. MCK: 0.15 )
Ranked among companies with meaningful Equity-to-Asset only.
MCK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13  Med: 0.26 Max: 0.35
Current: 0.15
0.13
0.35
Debt-to-Equity 0.97
MCK's Debt-to-Equity is ranked lower than
63% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. MCK: 0.97 )
Ranked among companies with meaningful Debt-to-Equity only.
MCK' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16  Med: 0.54 Max: 1.51
Current: 0.97
0.16
1.51
Debt-to-EBITDA 6.35
MCK's Debt-to-EBITDA is ranked higher than
66% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. MCK: 6.35 )
Ranked among companies with meaningful Debt-to-EBITDA only.
MCK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.04  Med: 1.73 Max: 6.35
Current: 6.35
1.04
6.35
Interest Coverage 10.57
MCK's Interest Coverage is ranked higher than
59% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. MCK: 10.57 )
Ranked among companies with meaningful Interest Coverage only.
MCK' s Interest Coverage Range Over the Past 10 Years
Min: 8.31  Med: 9.45 Max: 11.27
Current: 10.57
8.31
11.27
Piotroski F-Score: 5
Altman Z-Score: 4.01
Beneish M-Score: -2.58
WACC vs ROIC
9.90%
30.07%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 1.37
MCK's Operating Margin % is ranked lower than
54% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. MCK: 1.37 )
Ranked among companies with meaningful Operating Margin % only.
MCK' s Operating Margin % Range Over the Past 10 Years
Min: 1.12  Med: 1.82 Max: 1.91
Current: 1.37
1.12
1.91
Net Margin % 0.06
MCK's Net Margin % is ranked lower than
51% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. MCK: 0.06 )
Ranked among companies with meaningful Net Margin % only.
MCK' s Net Margin % Range Over the Past 10 Years
Min: 0.03  Med: 1.08 Max: 2.55
Current: 0.06
0.03
2.55
ROE % 1.15
MCK's ROE % is ranked higher than
98% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. MCK: 1.15 )
Ranked among companies with meaningful ROE % only.
MCK' s ROE % Range Over the Past 10 Years
Min: 0.64  Med: 18.14 Max: 50.65
Current: 1.15
0.64
50.65
ROA % 0.19
MCK's ROA % is ranked higher than
88% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. MCK: 0.19 )
Ranked among companies with meaningful ROA % only.
MCK' s ROA % Range Over the Past 10 Years
Min: 0.11  Med: 4.01 Max: 8.63
Current: 0.19
0.11
8.63
ROC (Joel Greenblatt) % 16.07
MCK's ROC (Joel Greenblatt) % is ranked higher than
97% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. MCK: 16.07 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MCK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 16.07  Med: 175.99 Max: 315.05
Current: 16.07
16.07
315.05
3-Year Revenue Growth Rate 9.40
MCK's 3-Year Revenue Growth Rate is ranked higher than
68% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. MCK: 9.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MCK' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.6  Med: 11.4 Max: 23.7
Current: 9.4
-13.6
23.7
3-Year EBITDA Growth Rate -25.80
MCK's 3-Year EBITDA Growth Rate is ranked higher than
93% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. MCK: -25.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MCK' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -68.1  Med: 15.4 Max: 297.2
Current: -25.8
-68.1
297.2
3-Year EPS without NRI Growth Rate -65.90
MCK's 3-Year EPS without NRI Growth Rate is ranked higher than
97% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. MCK: -65.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MCK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.9 Max: 87.1
Current: -65.9
0
87.1
GuruFocus has detected 3 Warning Signs with McKesson Corp MCK.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MCK's 30-Y Financials

Financials (Next Earnings Date: 2019-01-25 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2017

MCK Guru Trades in Q4 2017

Tom Russo 95 sh (New)
Pioneer Investments 391,307 sh (New)
Arnold Van Den Berg 97,950 sh (+13.94%)
Seth Klarman 1,360,000 sh (+172.00%)
Richard Pzena 2,600,401 sh (+5.77%)
John Buckingham 22,928 sh (+1.92%)
Steven Cohen 63,900 sh (+42.00%)
Larry Robbins 3,801,966 sh (+39.73%)
Ray Dalio 48,153 sh (+40.20%)
David Dreman 6,834 sh (unchged)
Tom Gayner 26,100 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Jim Simons Sold Out
Jerome Dodson Sold Out
Vanguard Health Care Fund 7,432,504 sh (-7.13%)
Ronald Muhlenkamp 69,947 sh (-1.42%)
George Soros 56,500 sh (-18.12%)
Joel Greenblatt 81,265 sh (-63.40%)
Charles Brandes 730,069 sh (-0.02%)
First Pacific Advisors 3,100 sh (-88.32%)
Diamond Hill Capital 1,662 sh (-56.05%)
» More
Q1 2018

MCK Guru Trades in Q1 2018

Jeremy Grantham 102,500 sh (New)
Ronald Muhlenkamp 71,090 sh (+1.63%)
George Soros 68,255 sh (+20.81%)
Seth Klarman 1,615,700 sh (+18.80%)
Richard Pzena 2,635,648 sh (+1.36%)
Tom Gayner 30,100 sh (+15.33%)
Steven Cohen 112,700 sh (+76.37%)
Diamond Hill Capital 1,663 sh (+0.06%)
Pioneer Investments 553,555 sh (+41.46%)
Larry Robbins 4,398,271 sh (+15.68%)
David Dreman 6,834 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Joel Greenblatt Sold Out
Tom Russo Sold Out
First Pacific Advisors Sold Out
Vanguard Health Care Fund 7,162,604 sh (-3.63%)
Arnold Van Den Berg 89,065 sh (-9.07%)
Charles Brandes 724,337 sh (-0.79%)
John Buckingham 21,543 sh (-6.04%)
Ray Dalio 5,251 sh (-89.10%)
» More
Q2 2018

MCK Guru Trades in Q2 2018

Joel Greenblatt 126,503 sh (New)
John Hussman 400 sh (New)
Paul Tudor Jones 30,487 sh (New)
Seth Klarman 1,627,700 sh (+0.74%)
Charles Brandes 727,626 sh (+0.45%)
Richard Pzena 2,836,710 sh (+7.63%)
Tom Gayner 37,100 sh (+23.26%)
John Buckingham 22,286 sh (+3.45%)
Diamond Hill Capital 2,317 sh (+39.33%)
Larry Robbins 4,710,544 sh (+7.10%)
Ray Dalio 56,752 sh (+980.78%)
Ronald Muhlenkamp 71,090 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Zeke Ashton 21,000 sh (unchged)
George Soros Sold Out
Steven Cohen Sold Out
Vanguard Health Care Fund 6,985,304 sh (-2.48%)
Jeremy Grantham 95,378 sh (-6.95%)
Pioneer Investments 137,291 sh (-75.20%)
Arnold Van Den Berg 88,299 sh (-0.86%)
» More
Q3 2018

MCK Guru Trades in Q3 2018

Jim Simons 699,400 sh (New)
Steven Cohen 33,900 sh (New)
Charles Brandes 772,121 sh (+6.12%)
Richard Pzena 3,160,195 sh (+11.40%)
Pioneer Investments 149,306 sh (+8.75%)
Larry Robbins 4,867,591 sh (+3.33%)
Joel Greenblatt 190,310 sh (+50.44%)
Seth Klarman 2,175,700 sh (+33.67%)
Arnold Van Den Berg 88,841 sh (+0.61%)
John Hussman 400 sh (unchged)
Vanguard Health Care Fund 6,985,304 sh (unchged)
Tom Gayner 37,100 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Diamond Hill Capital 2,273 sh (-1.90%)
Ronald Muhlenkamp 70,742 sh (-0.49%)
Ray Dalio 32,716 sh (-42.35%)
Jeremy Grantham 65,478 sh (-31.35%)
Paul Tudor Jones 27,804 sh (-8.80%)
John Buckingham 21,116 sh (-5.25%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:CAH, NYSE:ABC, XKRX:091990, NAS:HSIC, HKSE:01099, SHSE:601607, TSE:7459, SZSE:002589, SHSE:600056, SZSE:200028, LSE:UDG, SHSE:600763, NAS:PDCO, NZSE:EBO, SHSE:600090, NYSE:PBH, LSE:CLIN, SHSE:603368, TSE:7476, NYSE:OMI » details
Traded in other countries:MCK.Germany, MCK.Mexico,
Headquarter Location:USA
McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions.

McKesson is one of three major distributors of pharmaceuticals in the U.S. The firm also has significant specialty drug and medical product wholesaling operations. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy client and pharma manufacturing suppliers.

Guru Investment Theses on McKesson Corp

Weitz Funds Comments on McKesson - Jan 26, 2017

McKesson (NYSE:MCK) distributes drugs, equipment and health and beauty care products throughout North America and portions of Europe. The company also delivers software solutions and outsourced services to hospitals, pharmacies and other healthcare organizations. Shares of McKesson declined in October as the company experienced unexpected competitive losses from its core independent pharmacy customer base. The source (price competition) and magnitude of these developments led to a downward revision in McKesson’s earnings power and undermined one of the pillars of our investment thesis – that drug wholesalers operate within a competitive, but otherwise rational, oligopoly. Our estimate of McKesson’s business value declined, and we elected to close our small position at a modest loss.



From Weitz Investment Management's Value Fund fourth quarter 2016 commentary.



Check out Wallace Weitz latest stock trades

Top Ranked Articles about McKesson Corp

Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against McKesson Corporation
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against McKesson Corporation
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
INVESTOR NOTICE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK

Ratios

vs
industry
vs
history
PE Ratio 164.56
MCK's PE Ratio is ranked higher than
94% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.00 vs. MCK: 164.56 )
Ranked among companies with meaningful PE Ratio only.
MCK' s PE Ratio Range Over the Past 10 Years
Min: 5.98  Med: 17.29 Max: 510.1
Current: 164.56
5.98
510.1
Forward PE Ratio 7.94
MCK's Forward PE Ratio is ranked higher than
77% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.99 vs. MCK: 7.94 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 169.55
MCK's PE Ratio without NRI is ranked higher than
94% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.94 vs. MCK: 169.55 )
Ranked among companies with meaningful PE Ratio without NRI only.
MCK' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.83  Med: 17.18 Max: 545.28
Current: 169.55
5.83
545.28
Price-to-Owner-Earnings 58.40
MCK's Price-to-Owner-Earnings is ranked higher than
94% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.94 vs. MCK: 58.40 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MCK' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.59  Med: 12.53 Max: 70.43
Current: 58.4
3.59
70.43
PB Ratio 2.34
MCK's PB Ratio is ranked lower than
60% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.12 vs. MCK: 2.34 )
Ranked among companies with meaningful PB Ratio only.
MCK' s PB Ratio Range Over the Past 10 Years
Min: 1.31  Med: 2.94 Max: 6.98
Current: 2.34
1.31
6.98
PS Ratio 0.11
MCK's PS Ratio is ranked higher than
88% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. MCK: 0.11 )
Ranked among companies with meaningful PS Ratio only.
MCK' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: 0.32
Current: 0.11
0.08
0.32
Price-to-Free-Cash-Flow 8.31
MCK's Price-to-Free-Cash-Flow is ranked lower than
52% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. MCK: 8.31 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MCK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.4  Med: 12.23 Max: 41.89
Current: 8.31
5.4
41.89
Price-to-Operating-Cash-Flow 6.88
MCK's Price-to-Operating-Cash-Flow is ranked higher than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.02 vs. MCK: 6.88 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MCK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.87  Med: 10.22 Max: 89.13
Current: 6.88
4.87
89.13
EV-to-EBIT 61.92
MCK's EV-to-EBIT is ranked higher than
94% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.52 vs. MCK: 61.92 )
Ranked among companies with meaningful EV-to-EBIT only.
MCK' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.9  Med: 11.4 Max: 604.7
Current: 61.92
4.9
604.7
EV-to-EBITDA 20.28
MCK's EV-to-EBITDA is ranked higher than
96% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. MCK: 20.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
MCK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 9.1 Max: 37.3
Current: 20.28
4.3
37.3
EV-to-Revenue 0.14
MCK's EV-to-Revenue is ranked higher than
93% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. MCK: 0.14 )
Ranked among companies with meaningful EV-to-Revenue only.
MCK' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.4
Current: 0.14
0.1
0.4
PEG Ratio 105.94
MCK's PEG Ratio is ranked higher than
89% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. MCK: 105.94 )
Ranked among companies with meaningful PEG Ratio only.
MCK' s PEG Ratio Range Over the Past 10 Years
Min: 0.11  Med: 1.1 Max: 105.94
Current: 105.94
0.11
105.94
Shiller PE Ratio 15.35
MCK's Shiller PE Ratio is ranked higher than
67% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.63 vs. MCK: 15.35 )
Ranked among companies with meaningful Shiller PE Ratio only.
MCK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.98  Med: 27.94 Max: 51.74
Current: 15.35
14.98
51.74
Current Ratio 0.99
MCK's Current Ratio is ranked lower than
91% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. MCK: 0.99 )
Ranked among companies with meaningful Current Ratio only.
MCK' s Current Ratio Range Over the Past 10 Years
Min: 0.99  Med: 1.25 Max: 1.71
Current: 0.99
0.99
1.71
Quick Ratio 0.56
MCK's Quick Ratio is ranked lower than
91% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. MCK: 0.56 )
Ranked among companies with meaningful Quick Ratio only.
MCK' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.65 Max: 0.94
Current: 0.56
0.52
0.94
Days Inventory 30.48
MCK's Days Inventory is ranked higher than
67% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. MCK: 30.48 )
Ranked among companies with meaningful Days Inventory only.
MCK' s Days Inventory Range Over the Past 10 Years
Min: 29.24  Med: 30.99 Max: 32.98
Current: 30.48
29.24
32.98
Days Sales Outstanding 33.25
MCK's Days Sales Outstanding is ranked higher than
82% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 60.84 vs. MCK: 33.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
MCK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.36  Med: 25.99 Max: 33.25
Current: 33.25
24.36
33.25
Days Payable 60.77
MCK's Days Payable is ranked lower than
52% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. MCK: 60.77 )
Ranked among companies with meaningful Days Payable only.
MCK' s Days Payable Range Over the Past 10 Years
Min: 50.74  Med: 58.14 Max: 60.77
Current: 60.77
50.74
60.77

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.30
MCK's Dividend Yield % is ranked lower than
75% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. MCK: 1.30 )
Ranked among companies with meaningful Dividend Yield % only.
MCK' s Dividend Yield % Range Over the Past 10 Years
Min: 0.35  Med: 0.77 Max: 1.42
Current: 1.3
0.35
1.42
Dividend Payout Ratio 2.24
MCK's Dividend Payout Ratio is ranked higher than
96% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. MCK: 2.24 )
Ranked among companies with meaningful Dividend Payout Ratio only.
MCK' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.14 Max: 4.33
Current: 2.24
0.05
4.33
3-Year Dividend Growth Rate 10.60
MCK's 3-Year Dividend Growth Rate is ranked lower than
64% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. MCK: 10.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
MCK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -21.7  Med: 0 Max: 44.2
Current: 10.6
-21.7
44.2
Forward Dividend Yield % 1.39
MCK's Forward Dividend Yield % is ranked lower than
77% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. MCK: 1.39 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.04
MCK's 5-Year Yield-on-Cost % is ranked lower than
83% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.97 vs. MCK: 2.04 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MCK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.55  Med: 1.21 Max: 2.23
Current: 2.04
0.55
2.23
3-Year Average Share Buyback Ratio 4.50
MCK's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. MCK: 4.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MCK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -46.3  Med: 0.3 Max: 5.7
Current: 4.5
-46.3
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.49
MCK's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
92% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. MCK: 0.49 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MCK' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.49  Med: 0.98 Max: 30.68
Current: 0.49
0.49
30.68
Price-to-Intrinsic-Value-DCF (Earnings Based) 15.85
MCK's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
92% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.99 vs. MCK: 15.85 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
MCK' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.26  Med: 1.66 Max: 45.44
Current: 15.85
0.26
45.44
Price-to-Median-PS-Value 0.60
MCK's Price-to-Median-PS-Value is ranked higher than
60% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. MCK: 0.60 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MCK' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.51  Med: 1 Max: 1.92
Current: 0.6
0.51
1.92
Earnings Yield (Greenblatt) % 1.61
MCK's Earnings Yield (Greenblatt) % is ranked higher than
95% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.16 vs. MCK: 1.61 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MCK' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.2  Med: 8.8 Max: 20.6
Current: 1.61
0.2
20.6
Forward Rate of Return (Yacktman) % 10.63
MCK's Forward Rate of Return (Yacktman) % is ranked higher than
97% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.37 vs. MCK: 10.63 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MCK' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -23.5  Med: 21.8 Max: 30
Current: 10.63
-23.5
30

More Statistics

Revenue (TTM) (Mil) $210,927.00
EPS (TTM) $ 0.68
Beta1.57
Volatility24.90%
52-Week Range $111.27 - 178.86
Shares Outstanding (Mil)195.38

Analyst Estimate

Mar19 Mar20 Mar21
Revenue (Mil $) 214,825 221,526 228,561
EBIT (Mil $) 3,199 3,572 4,070
EBITDA (Mil $) 4,077 4,285 4,546
EPS ($) 11.51 12.60 14.75
EPS without NRI ($) 11.51 12.60 14.75
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.64%
Dividends per Share ($) 1.29 1.34 1.53

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for NYSE:MCK

Headlines

Articles On GuruFocus.com

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}